The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The head of the FDA’s artificial intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency, ...

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Reames heads up the DEA Seattle field office, which oversees the DEA's operations in Washington, Idaho, Oregon, and Alaska.

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...